Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989830418> ?p ?o ?g. }
- W2989830418 endingPage "50" @default.
- W2989830418 startingPage "44" @default.
- W2989830418 abstract "Abstract Introduction Acute respiratory infections (ARI) result in substantial annual morbidity among military personnel and decrease operational readiness. Herein, we summarize the research efforts of the Infectious Disease Clinical Research Program (IDCRP) related to ARIs. Methods The ARI Research Area of the IDCRP was established in response to the 2009 emergence of pandemic influenza A/H1N1. That year, IDCRP investigators deployed the ARI Consortium Natural History Study (ARIC NHS), a multi-centered, longitudinal observational study to assess etiology, epidemiology, and clinical characteristics of influenza-like illness (ILI) and severe acute respiratory infections (SARI) in the U.S. military. The success of this initial effort spurred implementation of several new initiatives. These include the FluPlasma trial, designed to evaluate the efficacy of hyperimmune anti-influenza plasma for the treatment of severe influenza; the self-administered live-attenuated influenza vaccine (SNIF) trial, which assessed the immunogenicity and acceptance of a self-administered live-attenuated influenza vaccine in military personnel; the Study to Address Threats of ARI in Congregate Military Populations (ATARI), a prospective study of ILI transmission, etiology and epidemiology in recruits; and the Flu Breath Test (FBT) study, a preliminary study of exhaled volatile organic compounds (VOC) in influenza patients. In addition, the InFLUenza Patient-Reported Outcome (FLU-PRO) survey, a daily diary to measure influenza symptoms during clinical trials, was developed. Lastly, the Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED) study, a two-year randomized trial designed to compare the effectiveness of the three types of licensed vaccines, launched in Fall 2018. Results The on-going ARIC NHS has enrolled over 2000 ILI and SARI cases since its inception, providing data on burden and clinical manifestations of ARI in military personnel and their families. The FluPlasma 2 trial concluded subject enrollment in 2018. Preliminary results from ATARI study show a high frequency of respiratory viruses circulating during the first two weeks of recruit training. Based on assessment of FLU-PRO responses, which were found to be reliable and reproducible, the survey may be a useful tool in clinical trials and epidemiological studies. The Flu Breath Study will complete enrollment in 2019. Findings from PAIVED are intended to provide evidence needed for assessing influenza vaccination policy in the military. Conclusions The ARI burden in the armed services remains significant every year and the threat is dynamic given emergent and evolving threats, such as influenzas. With strong successes to date, future initiatives of the ARI Research Area will focus on interventional studies, ARI transmission dynamics in congregate military settings, and determinants of risk of pandemic influenza and other emergent respiratory viruses." @default.
- W2989830418 created "2019-12-05" @default.
- W2989830418 creator A5007293184 @default.
- W2989830418 creator A5045370912 @default.
- W2989830418 creator A5058946644 @default.
- W2989830418 creator A5080884639 @default.
- W2989830418 date "2019-11-01" @default.
- W2989830418 modified "2023-09-29" @default.
- W2989830418 title "The Acute Respiratory Infection Consortium: A Multi-Site, Multi-Disciplinary Clinical Research Network in the Department of Defense" @default.
- W2989830418 cites W1498204857 @default.
- W2989830418 cites W157579434 @default.
- W2989830418 cites W1969176287 @default.
- W2989830418 cites W1983576126 @default.
- W2989830418 cites W2023844808 @default.
- W2989830418 cites W2085125153 @default.
- W2989830418 cites W2087670178 @default.
- W2989830418 cites W2107164582 @default.
- W2989830418 cites W2114529864 @default.
- W2989830418 cites W2131073664 @default.
- W2989830418 cites W2146442568 @default.
- W2989830418 cites W2223575612 @default.
- W2989830418 cites W2264983055 @default.
- W2989830418 cites W2293909840 @default.
- W2989830418 cites W2312460135 @default.
- W2989830418 cites W2579429733 @default.
- W2989830418 cites W2586795301 @default.
- W2989830418 cites W2616216241 @default.
- W2989830418 cites W2619617218 @default.
- W2989830418 cites W2749047254 @default.
- W2989830418 cites W2753442908 @default.
- W2989830418 cites W2761127894 @default.
- W2989830418 cites W2793400825 @default.
- W2989830418 cites W2793922718 @default.
- W2989830418 cites W2889891640 @default.
- W2989830418 cites W2898255325 @default.
- W2989830418 cites W2908441006 @default.
- W2989830418 cites W793806714 @default.
- W2989830418 cites W796060710 @default.
- W2989830418 cites W84987510 @default.
- W2989830418 doi "https://doi.org/10.1093/milmed/usz174" @default.
- W2989830418 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6886571" @default.
- W2989830418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31778194" @default.
- W2989830418 hasPublicationYear "2019" @default.
- W2989830418 type Work @default.
- W2989830418 sameAs 2989830418 @default.
- W2989830418 citedByCount "9" @default.
- W2989830418 countsByYear W29898304182020 @default.
- W2989830418 countsByYear W29898304182021 @default.
- W2989830418 countsByYear W29898304182022 @default.
- W2989830418 crossrefType "journal-article" @default.
- W2989830418 hasAuthorship W2989830418A5007293184 @default.
- W2989830418 hasAuthorship W2989830418A5045370912 @default.
- W2989830418 hasAuthorship W2989830418A5058946644 @default.
- W2989830418 hasAuthorship W2989830418A5080884639 @default.
- W2989830418 hasBestOaLocation W29898304181 @default.
- W2989830418 hasConcept C107130276 @default.
- W2989830418 hasConcept C126322002 @default.
- W2989830418 hasConcept C17744445 @default.
- W2989830418 hasConcept C177713679 @default.
- W2989830418 hasConcept C194828623 @default.
- W2989830418 hasConcept C199539241 @default.
- W2989830418 hasConcept C203014093 @default.
- W2989830418 hasConcept C22070199 @default.
- W2989830418 hasConcept C23131810 @default.
- W2989830418 hasConcept C2779072820 @default.
- W2989830418 hasConcept C2779134260 @default.
- W2989830418 hasConcept C2780689484 @default.
- W2989830418 hasConcept C3008058167 @default.
- W2989830418 hasConcept C524204448 @default.
- W2989830418 hasConcept C535046627 @default.
- W2989830418 hasConcept C71924100 @default.
- W2989830418 hasConcept C89623803 @default.
- W2989830418 hasConceptScore W2989830418C107130276 @default.
- W2989830418 hasConceptScore W2989830418C126322002 @default.
- W2989830418 hasConceptScore W2989830418C17744445 @default.
- W2989830418 hasConceptScore W2989830418C177713679 @default.
- W2989830418 hasConceptScore W2989830418C194828623 @default.
- W2989830418 hasConceptScore W2989830418C199539241 @default.
- W2989830418 hasConceptScore W2989830418C203014093 @default.
- W2989830418 hasConceptScore W2989830418C22070199 @default.
- W2989830418 hasConceptScore W2989830418C23131810 @default.
- W2989830418 hasConceptScore W2989830418C2779072820 @default.
- W2989830418 hasConceptScore W2989830418C2779134260 @default.
- W2989830418 hasConceptScore W2989830418C2780689484 @default.
- W2989830418 hasConceptScore W2989830418C3008058167 @default.
- W2989830418 hasConceptScore W2989830418C524204448 @default.
- W2989830418 hasConceptScore W2989830418C535046627 @default.
- W2989830418 hasConceptScore W2989830418C71924100 @default.
- W2989830418 hasConceptScore W2989830418C89623803 @default.
- W2989830418 hasFunder F4320306078 @default.
- W2989830418 hasFunder F4320332161 @default.
- W2989830418 hasIssue "Supplement_2" @default.
- W2989830418 hasLocation W29898304181 @default.
- W2989830418 hasLocation W29898304182 @default.
- W2989830418 hasLocation W29898304183 @default.
- W2989830418 hasOpenAccess W2989830418 @default.
- W2989830418 hasPrimaryLocation W29898304181 @default.
- W2989830418 hasRelatedWork W1984349242 @default.